Collaboration with Rimidi aimed at meeting residents' needs for chronic disease care. WOONSOCKET, R.I. (Oct. 16, 2018) — CVS Health (NYSE: CVS)
Rimidi closes $6.575 million Series A with strategic investment from Eli Lilly
Rimidi Inc., a digital health company that provides software and clinical analytics for chronic disease management, raised $6.575 million in Series
Rimidi names Josh Claman as CEO
Rimidi, a digital health company that provides software and clinical analytics for chronic disease management, appointed Josh Claman as president and
Rimidi partners with Eli Lilly for diabetes management initiative
Rimidi, a digital health company that provides software and clinical analytics for chronic disease management, and Eli Lilly and Co., a leader in
Rimidi named a Dexcom partner in glucose monitoring data platform
Rimidi,a provider of digital solutions to improve the management of chronic diseases, is an inaugural data partner in DexCom's newly launched open
Rimidi partners with Athenahealth’s ‘More Disruption Please’ program
Rimidi, a provider of digital solutions to improve the management of chronic diseases, announced a partnership with Athenahealth through that
Rimidi and Heritage Provider Network partnership expands to diabetes, congestive heart failure
Following a successful clinical trial and multisite pilot, Desert Oasis Healthcare, a medical group affiliated with Heritage Provider Network (HPN)
Rimidi to present at HIMSS 2017, highlight advances in interoperability
Rimidi, an Atlanta digital health company, is one of 12 businesses selected by the Georgia Economic Development Center to showcase its technology as
Rimidi Diabetes wins HILL Pitch Fest for diabetes management technology
Rimidi Diabetes took the top prize at the inaugural Healthways Innovation Living Lab (HILL) Pitch Fest ‘16, recognizing the most exciting companies in